Ticlopidine hydrochloride.
Ticlopidine, a new prototype antiplatelet agent, offers a significant alternative in the primary and secondary prevention of atherothrombotic stroke. While 2 multicenter trials demonstrated benefits of ticlopidine, this drug is not without risks and limitations and more studies are indicated. The neuroscience nurse must apply current knowledge about ticlopidine in the care for patients receiving ticlopidine therapy.
Blissitt
P A
PA
Baptist Memorial Hospital, Memphis.
D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000097:blood / Q000150:complications; D002542:Intracranial Embolism and Thrombosis / Q000097:blood / Q000517:prevention & control; D010353:Patient Education as Topic; D013988:Ticlopidine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D013988:Ticlopidine